# Alternative Treatment Methods for Hereditary ATTR Amyloidosis
Fladretinib (SARDiA study)
An experimental medication that aims to stop the formation of amyloid fibers in nerve tissue. It works through a different mechanism than standard treatments (it blocks certain growth factors involved in fluid accumulation in cells).
Animal studies have shown that this medication can slow nerve damage. Clinical trials are currently underway in patients to investigate its effectiveness and safety. It is not yet available on the market.
ExperimentaliOngoing in study setting, outcome still unknown
Herbal extracts and plant-based compounds
Various plant substances (such as polyphenols from green tea, turmeric, and other herbs) show effectiveness in the laboratory against the formation of amyloid protein fiber structures. Some studies suggest that these substances can slow the accumulation of misfolded proteins or even partially break them down.
This research is still in a very early stage. To date, no randomized clinical trials in humans have been conducted. It is unknown at what doses these substances would be effective, how well they are absorbed by the body, and whether this effect actually occurs in the human body.
ResearchediPositive results in clinical studies, not yet standard treatment
Immunotherapy (antibodies against amyloid)
Various research groups are working on antibodies that specifically target amyloid fibers or the misfolded transthyretin proteins themselves. The idea is that the body's own immune system can recognize and break down these harmful proteins.
This is still entirely in the experimental phase. A few small studies are underway, but there is no evidence yet from larger human trials.
ExperimentaliOngoing in study setting, outcome still unknown
Stem and progenitor cell therapy
Stem cells are being investigated as a possibility to repair damaged nerve tissue or suppress inflammatory reactions. Theoretically, certain types of stem cells could differentiate into supporting cells for nerves, or reduce inflammatory conditions in tissue.
To date, there are no clinical applications in hereditary ATTR amyloidosis. Research has not progressed beyond animal models.
ExperimentaliOngoing in study setting, outcome still unknown
Diets and supplementation
Many patients turn to certain diets (low-protein diets, intermittent fasting) or nutritional supplements (vitamin E, omega-3 fatty acids, magnesium, CoQ10) based on the belief that this can slow the disease or reduce symptoms. The biological mechanism would be that these substances inhibit inflammation or support the energy metabolism of cells.
There is no evidence that these measures can slow underlying ATTR amyloidosis or affect the progression of nerve and heart damage. Diets with very low protein intake can even be problematic because muscle tissue breaks down; this can worsen overall health.
UnproveniNo scientific evidence that it works
Rubbing, massage, and physiotherapy outside of standard protocols
Some patients try intensive massage or special manipulations to "loosen" tissue or remove amyloid. This is based on the misconception that amyloid can be mechanically displaced or loosened.
Amyloid is embedded in the tissue itself and cannot be removed through external manipulation. Intensive massage can further damage nerve-damaged areas and worsen pain.
Advised againstiProven ineffective or harmful, or dangerous in combination with your treatment
Chinese herbal medicine and traditional remedies without scientific evidence
In various cultures, herbs and traditional preparations are offered as "amyloid removers" or "energy restorers". Although some traditions show interesting biological activity in the laboratory, there is no evidence for effectiveness in people with hereditary ATTR.
Moreover, certain traditional remedies can cause interactions with standard ATTR medications or cause organ damage. Self-treatment with uncontrolled substances carries a risk.
Advised againstiProven ineffective or harmful, or dangerous in combination with your treatment
Limitations and caution
It is understandable that patients and family members look for alternatives, especially when regular treatments only slow down (not cure) the disease. Many alternative approaches sound appealing because they seem "natural" or sound plausible on theoretical grounds.
However:
- Hereditary ATTR amyloidosis is a demonstrable biological disease with specific genetic and protein-related causes. This requires targeted pharmacological intervention.
- Experimental medicines such as fladretinib and certain antibodies are precisely being *investigated* because laboratory results were promising — but human evidence is still lacking.
- Unproven medicines can be costly, give false hope, and interfere with regular treatment.
- Some "natural" preparations can be harmful or cause interactions.
If you are considering adding an alternative approach alongside your regular care, always discuss this with your doctor first, so that check-ups can be monitored and unexpected effects can be prevented.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._